The importance, future and limits of biotechnology - Start of the Biotechnology Days 2013
14/05/2013
Today and tomorrow, more than 600 entrepreneurs, researchers, politicians and investors will meet in Stuttgart to discuss the latest developments in the German biotechnology sector. Around two dozen symposia and plenary sessions as well as breakfast round tables and new, interactive conference formats will offer numerous opportunities to exchange views on successes, hurdles and future developments in the industry.
How has biotechnology changed our everyday lives? Is the industry underestimated?
How is it perceived and what will its future influence be? What prospects are being opened up by the convergence of medical technology and biotechnology, regenerative medicine, cell-free production systems and more automation? What role will biotechnology play in the future in the production of energy, raw materials and everyday consumer goods? Will chemistry become superfluous? How can companies emerge, grow and become profitable in the face of a shortage of skilled labour and a lack of venture capital? And are there also developments that need to be prevented?
The German biotechnology industry is doing well internationally in many areas, but there is still a lot to do. We therefore expect a lively discussion
The participants will address these and other questions. Guest lectures by representatives from other industries and politics will also provide impetus. biosaxony will also be on site to discuss the latest developments.
Since the last Biotechnology Days a year ago, the mood in the industry has brightened considerably: 2012 was a year of records for start-ups (20, +100%), employees (17,430, +7%) and turnover (€2.9 billion, +11%), but above all for takeovers (€1.1 billion, +190%). However, financing and expenditure on research and development continued to stagnate. This was the result of a recent survey commissioned by the Federal Ministry of Education and Research (biotechnologie.de 2013).
"The German biotechnology industry is doing well internationally in many areas, but there is still a lot to do. We therefore expect a lively discussion," says Viola Bronsema, Managing Director of Bio Deutschland e.V. "The industry has already been making significant contributions for years, not only to better medical care, but also to the reorganisation of the chemical industry and other sectors. As a result, the environment can be better protected and resources and energy can be saved. We want to take stock of this, but also highlight where there are still deficits and ask what is feasible and what is desirable."
The above texts, or parts thereof, were automatically translated from the original language text using a translation system (DeepL API).
Despite careful machine processing, translation errors cannot be ruled out.
